RTY-822

N/A

Report date: 2025/06/16 16:57:40
NME

Base Information

Drug NameRTY-822
Drug Alias NameRTY-822
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP Binding Cassette Subfamily C Member 6 modulators
TargetsATP Binding Cassette Subfamily C Member 6
Therapy Area/IndicationsVascular CalcificationNephrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRectify Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRectify Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsVascular CalcificationNephrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A